130 related articles for article (PubMed ID: 2688722)
1. Successful immunoadsorption with membrane plasmapheresis for multiple sclerosis.
Hosokawa S; Oyamaguchi A; Yoshida O
ASAIO Trans; 1989; 35(3):576-7. PubMed ID: 2688722
[TBL] [Abstract][Full Text] [Related]
2. Safety, stability, and effectiveness of immunoadsorption under membrane plasmapheresis treatment for myasthenia gravis.
Hosokawa S; Oyamaguchi A
ASAIO Trans; 1990; 36(3):M207-8. PubMed ID: 2252658
[TBL] [Abstract][Full Text] [Related]
3. Clinical studies on adequate dosage of heparin during immunoadsorption with membrane plasmapheresis.
Hosokawa S; Oyamaguchi A; Yoshida O
J Clin Apher; 1990; 5(4):197-200. PubMed ID: 2228999
[TBL] [Abstract][Full Text] [Related]
4. [The clinical use of protein-A immunoadsorption].
Aksenov VA
Ter Arkh; 1996; 68(11):83-5. PubMed ID: 9045392
[No Abstract] [Full Text] [Related]
5. [Plasmapheresis and immunosuppressive drugs in the treatment of multiple sclerosis].
Cendrowski W
Neurol Neurochir Pol; 1984; 18(3):259-62. PubMed ID: 6390235
[No Abstract] [Full Text] [Related]
6. Fibrinogen reduction and bleeding complications in plasma exchange, immunoadsorption and a combination of the two.
Zöllner S; Pablik E; Druml W; Derfler K; Rees A; Biesenbach P
Blood Purif; 2014; 38(2):160-6. PubMed ID: 25501972
[TBL] [Abstract][Full Text] [Related]
7. Immunoadsorption plasmapheresis for severe generalised myasthenia gravis.
Ichikawa M; Koh CS; Hata Y; Tohyama M; Tsuno T; Komiyama A
Arch Dis Child; 1993 Aug; 69(2):236-8. PubMed ID: 8215529
[TBL] [Abstract][Full Text] [Related]
8. Immunoadsorption with regenerating systems in neurological disorders --A single center experience.
Hohenstein B; Passauer J; Ziemssen T; Julius U
Atheroscler Suppl; 2015 May; 18():119-23. PubMed ID: 25936315
[TBL] [Abstract][Full Text] [Related]
9. [Immunoadsorption--a new treatment of myasthenia gravis].
Berning T; Krummenerl T; Glaser J; Paulus H; van Husen N
Med Klin (Munich); 1988 Feb; 83(4):125-8. PubMed ID: 3285161
[No Abstract] [Full Text] [Related]
10. Treatment of myasthenia gravis by immunoadsorption of plasma.
Grob D; Simpson D; Mitsumoto H; Hoch B; Mokhtarian F; Bender A; Greenberg M; Koo A; Nakayama S
Neurology; 1995 Feb; 45(2):338-44. PubMed ID: 7854536
[TBL] [Abstract][Full Text] [Related]
11. Immunoadsorption therapy and complement activation.
Pták J; Lochman J
Transfus Apher Sci; 2005 Jun; 32(3):263-7. PubMed ID: 15944112
[TBL] [Abstract][Full Text] [Related]
12. The levels of C3 and C4 components of the complement in the sera of relapsing-remitting multiple sclerosis patients (RR-MS) treated by 2-CDA (cladribine).
Bartosik-Psujek H; Stelmasiak Z; Mitosek-Szewczyk K; Belniak-Legieć E; Dobosz B
Ann Univ Mariae Curie Sklodowska Med; 2000; 55():231-4. PubMed ID: 11482079
[No Abstract] [Full Text] [Related]
13. Tryptophan-immobilized column adsorbs immunoglobulin G anti-GQ1b antibody from Fisher's syndrome: A new approach to treatment.
Yuki N
Neurology; 1996 Jun; 46(6):1644-51. PubMed ID: 8649564
[TBL] [Abstract][Full Text] [Related]
14. Immunoadsorption versus therapeutic plasma exchange. Will fibrinogen make the difference?
Honoré PM; Jacobs R; De Waele E; Van Gorp V; Spapen HD
Blood Purif; 2014; 38(2):158-9. PubMed ID: 25501843
[No Abstract] [Full Text] [Related]
15. [Immunoadsorption therapy for myasthenia gravis: study on the adsorption capacity of an immunoadsorption column].
Yeh JH; Chiu HC
J Microbiol Immunol Infect; 1999 Jun; 32(2):121-5. PubMed ID: 11565565
[TBL] [Abstract][Full Text] [Related]
16. Changes of plasma proteins after immunoadsorption using Ig-Adsopak columns in patients with myasthenia gravis.
Pták J
Transfus Apher Sci; 2004 Apr; 30(2):125-9. PubMed ID: 15062750
[TBL] [Abstract][Full Text] [Related]
17. Current topics on immunoadsorption therapy.
Nakaji S
Ther Apher; 2001 Aug; 5(4):301-5. PubMed ID: 11724516
[TBL] [Abstract][Full Text] [Related]
18. Combination of immunoadsorption therapy and high-dose methylprednisolone in patients with lupus nephritis; possible indications in patients with early stage.
Funauchi M; Ikoma S; Imada A; Kanamaru A
J Clin Lab Immunol; 1997; 49(2):47-57. PubMed ID: 9819673
[TBL] [Abstract][Full Text] [Related]
19. Immunoadsorption--a new therapeutic possibility for multiple sclerosis?
Schneidewind JM; Winkler R; Ramlow W; Tiess M; Hertel U; Sehland D
Transfus Sci; 1998 Mar; 19 Suppl():59-63. PubMed ID: 10178697
[TBL] [Abstract][Full Text] [Related]
20. Plasmapheresis and immunoadsorption in patients with steroid refractory multiple sclerosis relapses.
Faissner S; Nikolayczik J; Chan A; Hellwig K; Gold R; Yoon MS; Haghikia A
J Neurol; 2016 Jun; 263(6):1092-8. PubMed ID: 27039388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
